HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nethaji Muniraj Selected Research

Therapeutics

4/2024Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing.
12/2023Unleashing the Power of Yes-Associated Protein in Ferroptosis and Drug Resistance in Breast Cancer, with a Special Focus on Therapeutic Strategies.
1/2022Novel molecules as the emerging trends in cancer treatment: an update.
1/2022Comparable transforming growth factor beta-mediated immune suppression in ex vivo-expanded natural killer cells from cord blood and peripheral blood: implications for adoptive immunotherapy.
12/2021Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression.
8/2021Hyperleptinemia in obese state renders luminal breast cancers refractory to tamoxifen by coordinating a crosstalk between Med1, miR205 and ErbB.
1/2020Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment.
10/2019Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer.
3/2019Concomitant Inhibition of Cytoprotective Autophagy Augments the Efficacy of Withaferin A in Hepatocellular Carcinoma.
10/2017Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nethaji Muniraj Research Topics

Disease

12Neoplasms (Cancer)
04/2024 - 08/2017
9Breast Neoplasms (Breast Cancer)
12/2023 - 08/2017
3Carcinogenesis
01/2021 - 08/2017
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Obesity
08/2021
1Hepatocellular Carcinoma (Hepatoma)
03/2019
1Inflammation (Inflammations)
03/2019
1Rheumatic Diseases (Rheumatism)
02/2017
1Endometrial Neoplasms (Endometrial Cancer)
09/2010
1Carcinoma (Carcinomatosis)
10/2009

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
12/2023 - 01/2020
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2021 - 10/2019
2withaferin AIBA
09/2019 - 03/2019
1Chimeric Antigen ReceptorsIBA
01/2022
1Transforming Growth Factor beta (TGF-beta)IBA
01/2022
1AntigensIBA
01/2022
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
12/2021
1GANT 61IBA
12/2021
1Carboplatin (JM8)FDA LinkGeneric
12/2021
1TamoxifenFDA LinkGeneric
08/2021
1Hormones (Hormone)IBA
08/2021
1Phenobarbital (Luminal)FDA Link
08/2021
1LeptinIBA
08/2021
1CateninsIBA
01/2021
1Chloroquine (Aralen)FDA LinkGeneric
01/2020
1honokiolIBA
01/2020
1Etoposide (VP 16)FDA LinkGeneric
10/2019
1Paclitaxel (Taxol)FDA LinkGeneric
10/2019
1SilverIBA
10/2019
1Vinblastine (Vinblastine Sulfate)FDA Link
10/2019
1Vincristine (Oncovin)FDA LinkGeneric
10/2019
1LactonesIBA
09/2019
1Deoxyglucose (2 Deoxy D glucose)IBA
09/2019
1Histone Deacetylase InhibitorsIBA
03/2019
1CytokinesIBA
03/2019
1ChemokinesIBA
03/2019
1PhosphoproteinsIBA
10/2017
1benzyl isothiocyanateIBA
10/2017
1AdipokinesIBA
08/2017
1Phosphotransferases (Kinase)IBA
08/2017
1AdiponectinIBA
08/2017
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
02/2017
1Human Growth Hormone (Saizen)FDA LinkGeneric
09/2010
1Protein Isoforms (Isoforms)IBA
09/2010
1Trefoil Factor-1IBA
10/2009

Therapy/Procedure

10Therapeutics
04/2024 - 10/2017
2Immunotherapy
03/2023 - 01/2022
2Drug Therapy (Chemotherapy)
01/2022 - 08/2017
1Aftercare (After-Treatment)
03/2019